late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device ...

The U.S. contract research organization market exceeded USD 13.1 billion revenue in 2017 and is projected to register 7%+ CAGR during the forecast timeframe due to technological advances and wide ...

The Contract Research Organization (CRO ... intensified research efforts to develop advanced therapies and medical devices, leading to an upsurge in clinical trial activity.

Fortrea Holdings Inc.’s FTRE share price has surged by 5.64%, which has investors questioning if this is right time to sell.